Why Phibro Animal Health Corp’s (PAHC) Stock Is Up 13.88%

By Jenna Brashear
December 04, 2023
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Phibro Animal Health Corp before investing.

In this article, we go over a few key elements for understanding Phibro Animal Health Corp’s stock price such as:

  • Phibro Animal Health Corp’s current stock price and volume
  • Why Phibro Animal Health Corp’s stock price changed recently
  • Upgrades and downgrades for PAHC from analysts
  • PAHC’s stock price momentum as measured by its relative strength

About Phibro Animal Health Corp (PAHC)

Before we jump into Phibro Animal Health Corp’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Phibro Animal Health Corporation is a diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 770 product lines in over 80 countries to approximately 4,000 customers. The Company has three segments. Animal Health segment develops, manufactures and markets about 270 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. Mineral Nutrition segment manufactures and markets approximately 420 formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries, predominantly in the United States.

Want to learn more about Phibro Animal Health Corp’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Phibro Animal Health Corp.

Learn More About A+ Investor

Phibro Animal Health Corp’s Stock Price as of Market Close

As of December 04, 2023, 4:00 PM, CST, Phibro Animal Health Corp’s stock price was $11.24.

Phibro Animal Health Corp is up 13.88% from its previous closing price of $9.87.

During the last market session, Phibro Animal Health Corp’s stock traded between $9.50 and $10.02. Currently, there are 40.50 million shares of Phibro Animal Health Corp stock available for purchase.

Phibro Animal Health Corp’s price-earnings (P/E) ratio is currently at 19.3, which is low compared to the Pharmaceuticals industry median of 26.9. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Phibro Animal Health Corp Stock Price History

Phibro Animal Health Corp’s (PAHC) price is currently up 17.21% so far this month.

During the month of December, Phibro Animal Health Corp’s stock price has reached a high of $11.26 and a low of $9.50.

Over the last year, Phibro Animal Health Corp has hit prices as high as $16.52 and as low as $9.40. Year to date, Phibro Animal Health Corp’s stock is down 44.96%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Phibro Animal Health Corp Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of December 01, 2023, there were 2 analysts who downgraded Phibro Animal Health Corp’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Phibro Animal Health Corp’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Phibro Animal Health Corp’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Phibro Animal Health Corp’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Phibro Animal Health Corp (PAHC) by visiting AAII Stock Evaluator.

Relative Price Strength of Phibro Animal Health Corp

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of December 01, 2023, Phibro Animal Health Corp has a weighted four-quarter relative price strength of -10.77%, which translates to a Momentum Score of 30 and is considered to be Weak.

Want to learn more about how Phibro Animal Health Corp is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Phibro Animal Health Corp Stock Price: Bottom Line

As of December 4, 2023, Phibro Animal Health Corp’s stock price is $11.24, which is up 13.88% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Phibro Animal Health Corp stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
High Relative Dividend
Yield Screen:
8.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.